Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_assertion type Assertion NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_head.
- NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_assertion description "[30% of the PTLD had a germinal center (GC) profile (CD10, bcl-6, MUM-1/IRF4, CD138), 53% a late GC/early post-GC profile (CD10, bcl-6, MUM-1/IRF4, CD138), 13% a post-GC profile (CD10, bcl-6, MUM-1/IRF4, CD138) and 3% an indeterminate profile (all markers negative).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_provenance.
- NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_assertion evidence source_evidence_literature NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_provenance.
- NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_assertion SIO_000772 17122518 NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_provenance.
- NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_assertion wasDerivedFrom befree-2016 NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_provenance.
- NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_assertion wasGeneratedBy ECO_0000203 NP580702.RACKCCKaMftXIzFbZLRTDvJ43abwUmDVzfIcdrjsiesXY130_provenance.